Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022

SELL
$0.58 - $1.09 $11,020 - $20,710
-19,000 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$0.93 - $1.18 $17,670 - $22,420
19,000 New
19,000 $21,000
Q1 2021

Apr 26, 2021

SELL
$1.62 - $3.05 $30,780 - $57,950
-19,000 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$0.8 - $2.33 $15,200 - $44,270
19,000 New
19,000 $33,000
Q2 2020

Jul 22, 2020

SELL
$0.75 - $1.29 $13,500 - $23,220
-18,000 Closed
0 $0
Q4 2019

Jan 29, 2020

SELL
$1.23 - $2.67 $63,960 - $138,840
-52,000 Reduced 74.29%
18,000 $29,000
Q3 2019

Oct 25, 2019

BUY
$1.25 - $5.0 $22,500 - $90,000
18,000 Added 34.62%
70,000 $153,000
Q2 2019

Jul 30, 2019

BUY
$1.65 - $6.72 $57,750 - $235,200
35,000 Added 205.88%
52,000 $104,000
Q1 2019

Apr 18, 2019

BUY
$4.84 - $9.07 $82,280 - $154,190
17,000 New
17,000 $119,000
Q4 2018

Jan 24, 2019

SELL
$4.21 - $14.28 $90,515 - $307,020
-21,500 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$13.02 - $17.54 $279,930 - $377,110
21,500 New
21,500 $301,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Bfsg, LLC Portfolio

Follow Bfsg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.